Vita Life Sciences Ltd
ASX:VLS

Watchlist Manager
Vita Life Sciences Ltd Logo
Vita Life Sciences Ltd
ASX:VLS
Watchlist
Price: 2.19 AUD -0.45% Market Closed
Market Cap: 120.8m AUD

Operating Margin
Vita Life Sciences Ltd

14.9%
Current
17%
Average
6.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.9%
=
Operating Profit
11.9m
/
Revenue
79.5m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
Vita Life Sciences Ltd
ASX:VLS
123.9m AUD
15%
US
Eli Lilly and Co
NYSE:LLY
744B USD
40%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
362.6B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
2.2T DKK
45%
CH
Roche Holding AG
SIX:ROG
206.8B CHF
33%
CH
Novartis AG
SIX:NOVN
186.5B CHF
33%
UK
AstraZeneca PLC
LSE:AZN
163.6B GBP
24%
US
Merck & Co Inc
NYSE:MRK
199.5B USD
34%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
11%
US
Pfizer Inc
NYSE:PFE
135.8B USD
27%

Vita Life Sciences Ltd
Glance View

Market Cap
123.9m AUD
Industry
Pharmaceuticals

Vita Life Sciences Ltd. engages in the formulation, packaging, sale and distribution of vitamins and supplements. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-08-23. The firm is involved in the formulating, packaging, sales and distributing vitamins and supplements. The Company’s core business is the development and distribution of over the counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. The company offers products under the brands, such as Herbs of Gold, VitaHealth, VitaScience and VitaLife. The firm operates in Australia, Singapore, Malaysia and others. The firm subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed Bio Sciences Pty Limited, Allrad No 19 Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited, VitaHealth Laboratories Australia Pty Limited and Vita Institute of Health Pty Ltd.

VLS Intrinsic Value
2.42 AUD
Undervaluation 10%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.9%
=
Operating Profit
11.9m
/
Revenue
79.5m
What is the Operating Margin of Vita Life Sciences Ltd?

Based on Vita Life Sciences Ltd's most recent financial statements, the company has Operating Margin of 14.9%.

Back to Top